Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation
- 1 March 2007
- journal article
- review article
- Published by Frontiers Media SA in Transplant International
- Vol. 20 (3) , 207-218
Abstract
Post-transplant lymphoproliferative disorder (PTLD) is a serious and still frequently observed complication of solid organ transplantation. Despite the recent introduction of anti B-cell monoclonal antibody therapy (rituximab) for treatment of PTLD, mortality rates remain high. Because PTLD often presents in a nonspecific way in clinically unsuspected patients, it is a major challenge to diagnose PTLD at an early stage. Epstein-Barr virus (EBV)-DNA load monitoring is a promising tool for the identification of patients at risk for PTLD development. However, there are some limitations of this method, and not all patients at risk for PTLD can be identified by EBV-DNA measurements alone. Therefore, it is of major importance to recognize early clinical signs and symptoms of PTLD. In this review, risk factors for PTLD development, disease presentation, and methods for early detection will be discussed. Special attention is given to allograft and digestive tract localization and the relation with time of onset of PTLD. The value and pitfalls of EBV-DNA load monitoring are discussed. In addition, because fluorodeoxyglucose (FDG)-positron emission tomography (PET) has shown to be a powerful tool for staging and response evaluation of malignant lymphoma, the role of FDG-PET for early diagnosis and staging of PTLD is addressed.Keywords
This publication has 110 references indexed in Scilit:
- Treatment of solid organ transplant recipients with autologous Epstein Barr virus–specific cytotoxic T lymphocytes (CTLs)Blood, 2006
- Management of patients with post-transplant lymphoproliferative disorder: the role of rituximabTransplant International, 2006
- Sinonasal Posttransplant Lymphoproliferative Disorder in Pediatric Lung Transplant PatientsOtolaryngology–Head and Neck Surgery, 2005
- Epstein – Barr viral load, interleukin-6 and interleukin-10 levels in post-transplant lymphoproliferative disease: A nested case – control study in a renal transplant cohortLeukemia & Lymphoma, 2005
- IFN-γ gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID miceBlood, 2005
- Posttransplant lymphoproliferative disorders presenting at sites of previous surgical interventionTransplantation, 2003
- Orbital presentation of posttransplantation lymphoproliferative disorderOphthalmology, 2002
- Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patientsTransplantation, 2002
- Rapid Occurrence of Lymphoproliferative Disease After Pancreas-Kidney Transplantation Performed During Acute Primary Epstein-Barr Virus InfectionClinical Infectious Diseases, 1997
- LYMPHOPROLIFERATIVE DISORDER MASQUERADING AS REJECTION IN LIVER TRANSPLANT RECIPIENTS-AN EARLY AGGRESSIVE TUMOR WITH TYPICAL PRESENTATIONTransplantation, 1992